EUVIMEDEUVIMED entdecken
Querschnittstudie

Serum Insulin Receptor Substrate-1 as a Biomarker of Insulin Resistance and Metabolic Syndrome in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study from Baghdad, Iraq

A.S. Alghadhanfari, H.L. Al-Omary, O.F. Al-Azzawi

Лабораторная диагностика. Восточная Европа · 30.09.2026 · 15 (3(S)) · 118-127

DOI: 10.34883/pi.2026.15.3.057 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Лабораторная диагностика. Восточная Европа, online erschienen am 30.09.2026. Verfasst von A.S. Alghadhanfari und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Insulin receptor substrate-1 (IRS-1) is the principal docking protein in the insulin signaling cascade, and its impairment is a core molecular lesion of insulin resistance. Whether circulating serum IRS-1 can serve as a clinically useful biomarker of insulin resistance and metabolic syndrome in type 2 diabetes mellitus (T2DM) remains poorly characterized in Middle-Eastern populations.

Purpose

To evaluate serum IRS-1 as a biomarker of insulin resistance (HOMA-IR) and metabolic syndrome in Iraqi adults with T2DM at risk of metabolic syndrome, and to compare its discriminative performance with that of DEXA-derived visceral fat percentage and standard anthropometric indices. Materials and methods. A cross-sectional hospital-based study enrolled 68 adults with established T2DM at Baghdad Teaching Hospital. Serum IRS-1 was measured by sandwich enzyme-linked immunosorbent assay (ELISA), HOMA-IR was calculated from fasting insulin and glucose, and DEXA quantified regional visceral fat. Metabolic syndrome was defined using the harmonized 2009 criteria. Spearman correlation, group comparisons, receiver operating characteristic (ROC) analysis, and multiple linear regression for ln(HOMA-IR) were performed using SPSS v.26.

Results

Patients were predominantly female (69.1%), with a mean age of 52.1 years and a mean serum IRS-1 of 1.98±0.64 ng/mL. Metabolic syndrome was present in 43 of 68 patients (63.2%). Serum IRS-1 was strongly inversely correlated with HOMA-IR (Spearman ρ=–0.496, p

Zitieren

APA

Alghadhanfari, A., Al-Omary, H., & Al-Azzawi, O. (2026). Serum Insulin Receptor Substrate-1 as a Biomarker of Insulin Resistance and Metabolic Syndrome in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study from Baghdad, Iraq. Лабораторная диагностика. Восточная Европа, 15(3(S)), 118-127. https://doi.org/10.34883/pi.2026.15.3.057

Vancouver

Alghadhanfari A, Al-Omary H, Al-Azzawi O. Serum Insulin Receptor Substrate-1 as a Biomarker of Insulin Resistance and Metabolic Syndrome in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study from Baghdad, Iraq. Лабораторная диагностика. Восточная Европа. 2026;15(3(S)):118-127. doi:10.34883/pi.2026.15.3.057

BibTeX
@article{Alghadhanfari2026,
  author = {Alghadhanfari, A.S. and Al-Omary, H.L. and Al-Azzawi, O.F.},
  title = {Serum Insulin Receptor Substrate-1 as a Biomarker of Insulin Resistance and Metabolic Syndrome in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study from Baghdad, Iraq},
  journal = {Лабораторная диагностика. Восточная Европа},
  year = {2026},
  volume = {15},
  number = {3(S)},
  pages = {118--127},
  doi = {10.34883/pi.2026.15.3.057}
}
Kostenlos starten →